Clinical trials
Ventricular Arrhythmia clinical trials
Below are recruiting ventricular arrhythmia clinical trials, each written for real people, not researchers. We’re tracking 56 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT05034432RecruitingPhase 4
Test treatment for dangerous heart rhythm episodes in LVAD patients
This trial studies a procedure to fix abnormal heart rhythms (ventricular tachycardia or ventricular fibrillation) in people who have an LVAD and a defibrillator (ICD) or an alternative device. It may help prevent future dangerous rhythm episodes after LVAD treatment.
Phoenix, ArizonaAges 18 years+ - NCT06591260Recruiting
Heart biopsy and treatment for kids with heart inflammation
This study looks at using heart biopsies to find the cause of heart inflammation (myocarditis) in children and then tailoring treatment to that cause. It aims to improve care for children with or without irregular heartbeats.
Milan, MilanoAges birth–17 years - NCT04088071Recruiting
Ablation for heart rhythm problems using a specific technology
This study looks at how well catheter ablation works for treating certain heart rhythm disorders (like atrial fibrillation or ventricular arrhythmias) using a specific brand of catheters. The aim is to gather real-world data to better understand the procedure's outcomes.
Birmingham, AlabamaAges 18 years+ - NCT07436962Recruiting
Loop recorder for mitral valve heart condition
This trial tests whether a small heart monitor (loop recorder) can help people with a specific mitral valve condition called mitral annular disjunction. It's for patients who have scar tissue in their heart muscle shown on an MRI.
BudapestAges 18–60 - NCT05594368RecruitingPhase 1
Test targeted radiation to treat recurrent ventricular tachycardia
This trial studies a radiation approach (called stereotactic body radiation therapy, or SBRT) to treat ventricular tachycardia (a dangerous heart rhythm) that keeps coming back. It aims to reduce the rhythm episodes in people who have already tried catheter ablation (a procedure to cauterize rhythm sources) or cannot have it.
OstravaAges 18 years+ - NCT06255457Recruiting
Heart rhythm study for patients getting mitral valve surgery
This study looks at heart rhythm problems in people having mitral valve surgery to fix a leaky valve. It may help doctors better understand who is at risk for dangerous rhythms.
Stockholm, Stockholm CountyAges 18 years+ - NCT06730464Recruiting
Predicting dangerous heart rhythms in non-ischemic heart disease
This study uses heart MRI scans to predict who might develop dangerous heart rhythms. It's for people with certain types of non-ischemic heart disease who have already had an MRI with contrast.
Milan, ItalyAges 18 years+ - NCT06730607Recruiting
Predicting heart rhythm problems after myocarditis
This study uses heart MRI scans to predict who might develop dangerous heart rhythms after recovering from myocarditis. It aims to find better ways to monitor patients and prevent emergencies.
Rozzano, MilanAges 18 years+ - NCT07137455Enrolling by invitation
New system to record and classify heart electrical signals
This trial is testing a new recording system that helps doctors see and classify the heart's electrical signals during a routine heart procedure. It may improve how doctors treat abnormal heart rhythms or place pacemakers.
Atlanta, GeorgiaAges 21–100 - NCT06425822Recruiting
Studying the left atrium in ventricular arrhythmia patients
This trial studies the upper left chamber of the heart (the left atrium) in people who have fast or irregular heartbeats from the lower chambers (ventricular arrhythmias). The goal is to see if there are specific patterns in the left atrium that might be linked to these arrhythmias, which could help tailor treatments in the future.
Jette, Brussels CapitalAges 18 years+ - NCT04921501Recruiting
Testing a detailed heart tracing to evaluate rhythm risks
This study checks a more detailed kind of heart recording (ECG) using many small sensors to better measure electrical rhythm problems. It may help doctors refine how they assess risk in people with serious or suspected dangerous heart rhythm issues.
Clermont-FerrandAges 14 years+ - NCT07211347RecruitingPhase 4
Nerve block for electrical storm
This trial tests whether injecting numbing medicine around neck nerves (stellate ganglion block) can calm dangerous heart rhythms called electrical storm. It's for people with heart disease whose abnormal rhythms keep happening despite usual medications.
São Paulo, São PauloAges 18 years+ - NCT07205757RecruitingPhase 4
Lidocaine added to Custodiol for heart bypass surgery
This study tests whether adding lidocaine to the standard heart preservation solution (Custodiol) helps protect the heart during coronary artery bypass surgery. If you are scheduled for elective bypass surgery, this trial might be relevant to you.
Al FayyumAges 18 years+ - NCT06602635Recruiting
New scoring system for outflow tract arrhythmias with wide QRS
This study is testing a new scoring system (called a Hybrid Score) to better predict the origin of ventricular arrhythmias coming from the outflow tract of the heart. The goal is to improve treatment planning for people with a wide QRS complex on their ECG.
Brussels, BelgiumAges 18 years+ - NCT06835491RecruitingPhase 3
Amiodarone to prevent heart rhythm problems after cardiac arrest
This trial tests whether giving the drug amiodarone early can prevent dangerous heart rhythm problems in patients who survived a cardiac arrest with a shockable rhythm. If it works, it could help more people recover.
AmiensAges 18 years+ - NCT06964464RecruitingPhase 4
Comparing two heart failure medications in ICD patients
This trial compares two beta-blocker medications, carvedilol and metoprolol succinate, to see which one works better for people with heart failure who have an implantable cardioverter defibrillator (ICD). If you are currently taking metoprolol succinate, you may be able to switch to carvedilol and help researchers find the best treatment.
Scottsdale, ArizonaAges 18 years+ - NCT07374263Recruiting
Do heart rhythm drugs pose risks in hospital?
This study looks at whether certain medications that can affect heart rhythm (QT-prolonging drugs) are linked to serious heart problems in adults who were hospitalized. It includes patients admitted to St. Joseph's Healthcare Hamilton or other GEMINI hospitals between 2017 and 2025.
Hamilton, OntarioAges 18 years+ - NCT01999140Recruiting
ICD and CRT-D device registry for patients worldwide
This trial is a real-world registry that collects information from people who receive an implantable heart defibrillator or related device. It helps doctors understand how these devices are used and how patients do over time.
Washington D.C., District of ColumbiaAges Any age - NCT06743789Recruiting
Radiation therapy for ventricular tachycardia: one or three sessions
This trial tests whether a single session of targeted radiation (radioablation) is as effective as three sessions for treating a dangerous heart rhythm called ventricular tachycardia in people with heart muscle disease. It's for those who continue to have episodes despite medication and catheter ablation.
New York, New YorkAges 18–90 - NCT05439031RecruitingPhase 2
Stereotactic radiation to reduce recurrent dangerous heart rhythm episodes
This Phase 2 study tests a precise form of radiation therapy to control recurrent ventricular tachycardia (VT), a dangerous fast heart rhythm. It may help people whose VT keeps coming back despite heart medicines and/or ablation, especially when ablation is not possible.
Amsterdam, North HollandAges 18 years+ - NCT03049254Recruiting
Registry and blood/tissue study for certain sudden heart death causes
This study builds a registry and collection of samples to better understand families affected by sudden heart death and related heart rhythm problems that are not clearly caused by a heart attack. It may help researchers identify patterns and improve future care, and it offers a way for patients and families to contribute to research.
Rochester, MinnesotaAges Any age - NCT07024927Recruiting
Heart rhythm disorder registry
This study observes people with atrial fibrillation or ventricular tachycardia who are having their first catheter ablation procedure. The goal is to collect information to improve future treatments.
Beijing, Beijing MunicipalityAges 18 years+ - NCT07096973Recruiting
Heart rehab recovery study in Davos
This study looks at how people recover during heart rehabilitation at a clinic in Davos. By tracking your progress, researchers hope to learn what helps people get better.
Davos, Kanton GraubündenAges 18 years+ - NCT07428967Recruiting
Pacemaker after heart procedure for atrial fibrillation
This trial tests a new type of pacemaker for people with atrial fibrillation who are scheduled for a procedure that disconnects the heart's natural electrical pathway. It may help improve symptoms and heart function.
HagenAges 18 years+
Hear when a new Ventricular Arrhythmia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for ventricular arrhythmia?
- Yes. Clin2 currently lists 56 recruiting ventricular arrhythmia studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a ventricular arrhythmia trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a ventricular arrhythmia trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.